Ahmadinejad Period Islamic Republic of Iran: Relations with Hezbollah
Bu tez size mi ait?
Bu kayıt toplu arşivden geldi. Sizinse profilinize bağlayın.
Özet (EN)
The Hezbollah organization, which emerged in Lebanon, has been an important political and military actor in Lebanon and the Middle East since its inception. The Hezbollah organization, which was considered "terrorist" by some countries as both political and military, was influenced by a number of internal and external dynamics in the organization and growth phase. For a better understanding of the structure and impact power of the organization, these dynamics must be examined individually. In terms of external dynamics, Hezbollah has been in intense relations with Iran in both the founding phase and the following period. In this context, primarily the internal and external dynamics will be examined, and the Iranian relations, which are the ideological and political common denominators of the Organization, will be examined especially during the Ahmadinejad period (2005-2013). Key Words: Terrorism, Hezbollah, Iran, Ahmadinejad, Lebanon
Yazar
Yıldız Gözde Gürsel
Kurum
Bu Yayına Nasıl Atıf Yapılır
Yıldız Gözde Gürsel (Master Thesis). Ahmadinejad Period Islamic Republic of Iran: Relations with Hezbollah, 2019, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)